SYNTHETIC PEPTIDES AND OTHER DRUGS OF ABUSE; PURITY DETERMINATION, STABILITY TESTING AND QUANTITATIVE ANALYSIS. NIDA REF. NO. N01DA-18-8945; POP: 09/2

合成肽和其他滥用药物；

• 批准号: 10285134
• 负责人: LEANNE CHAN
• 金额: $ 38.69万
• 依托单位: SRI INTERNATIONAL
• 依托单位国家: 美国
• 财政年份: 2018
• 资助国家: 美国
• 起止时间: 2018-09-29 至 2021-09-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10285134
• 关键词: Chemicals; Contracts; Equipment and supply inventories; Methods; Monitor; National Institute of Drug Abuse; Opioid; Peptides; Pharmaceutical Preparations; Research; Research Personnel; Services; drug of abuse; peptide drug; stability testing; synthetic peptide

Specifically, NIDA through this contract plans to (1) analyze and establish the purity of peptides that are synthesized through NIDA contracts, (2) regularly monitor the purity and stability of these peptides, and (3) develop methods and analyze various drugs of abuse and other probes available in the drug supply inventory for purity and authenticity verification as needed.

具体来说，NIDA 通过该合同计划 (1) 分析和确定通过 NIDA 合同合成的肽的纯度，(2) 定期监测这些肽的纯度和稳定性，以及 (3) 开发方法并分析各种滥用药物以及药物供应库存中可用的其他探针，用于根据需要验证纯度和真实性。